SynthesisFrontiers in pharmacology2024

Efficacy and safety of PARP inhibitors combined with antiangiogenic agents in the maintenance treatment of ovarian cancer: a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials.

Yan Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.